This program provides a comprehensive overview of ceftriaxone, focusing on its mechanism of action, spectrum of activity, and key pharmacokinetic and pharmacodynamic properties.

This conference aims to improve healthcare professional knowledge, attitudes, and perceived barriers regarding opioid harm reduction strategies amongst vulnerable populations and expand the capacity for harm reduction efforts in underserved communities in the Deep South and nationally.